Skip to Content

Stratec SE SRBZF

Morningstar Rating
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SRBZF is trading at a 41% discount.
Price
$73.26
Fair Value
$384.49
Uncertainty
Very High
1-Star Price
$351.58
5-Star Price
$91.48
Economic Moat
Xcd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SRBZF is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
32.21
Price/Sales
3.82
Dividend Yield
1.28%
Dividend Yield (Forward)
1.42%
Total Yield
1.28%

Company Profile

Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
1,532

Valuation

Metric
SRBZF
Price/Earnings (Normalized)
32.21
Price/Book Value
5.09
Price/Sales
3.82
Price/Cash Flow
20.48
Price/Earnings
SRBZF

Financial Strength

Metric
SRBZF
Quick Ratio
0.85
Current Ratio
2.28
Interest Coverage
5.96
Quick Ratio
SRBZF

Profitability

Metric
SRBZF
Return on Assets (Normalized)
3.58%
Return on Equity (Normalized)
6.65%
Return on Invested Capital (Normalized)
5.06%
Return on Assets
SRBZF

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesYccnds$180.6 Bil
SYK
Stryker CorpZvg$109.9 Bil
MDT
Medtronic PLCKtrsp$105.8 Bil
BSX
Boston Scientific CorpMqmqfp$80.6 Bil
DXCM
DexCom IncZtfd$45.4 Bil
EW
Edwards Lifesciences CorpWsmfxq$41.4 Bil
ZBH
Zimmer Biomet Holdings IncCtj$24.5 Bil
PHG
Koninklijke Philips NV ADRYjzch$18.1 Bil
ALGN
Align Technology IncFtxqkc$16.6 Bil
PODD
Insulet CorpLhgxfc$13.6 Bil